Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Clinical trials of cefoxitin, a new cephamycin antibiotic were carried out on 17 infantile patients with infections (respiratory tract infection 15, meningitis 1 and sepsis 1). Two patients of the above patients were excluded from the clinical evaluation except side effects because diseases were out...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/7289023
データ提供:米国国立医学図書館(NLM)
A Clinical Study of Cefoxitin in Children
This study delves into the realm of pediatric infectious diseases. The researchers employed a clinical trial approach to investigate the efficacy and safety of cefoxitin, a novel antibiotic belonging to the cephamycin family, in treating infections among young patients. The study involved 17 children suffering from various infections, primarily respiratory tract infections, with a smaller number experiencing meningitis and sepsis. The researchers meticulously documented the clinical outcomes, including the effectiveness of cefoxitin in combating the infections, and any adverse events associated with the treatment. This research sheds light on the potential of cefoxitin as a therapeutic option in pediatric infectious disease management.
Cefoxitin Shows Promise in Treating Pediatric Infections
The results indicate a favorable efficacy rate of 73.3%, with a majority of the patients exhibiting good to fair responses to the treatment. This suggests that cefoxitin holds promise as a potential treatment option for pediatric infections. However, it's important to acknowledge that a portion of the patients experienced side effects, highlighting the need for careful monitoring and individualised treatment approaches.
Understanding Potential Side Effects and Personalized Care
While cefoxitin appears to be a promising treatment for pediatric infections, it's crucial to be aware of the potential side effects that can occur in a small number of patients. This underscores the importance of personalized care and close monitoring during treatment, ensuring the safety and well-being of our youngest patients. It's a reminder that, as with any medical intervention, there are always trade-offs to consider, and individual responses to treatments can vary.
Dr.Camel's Conclusion
Just like navigating a vast desert, treating infections in children requires a careful balance. This study helps us understand the potential benefits and risks of cefoxitin, guiding us towards more personalized and effective treatments. We must always remember, just as the desert holds both beauty and challenges, treating children's infections involves careful consideration and a commitment to their well-being.
Date :
- Date Completed 1981-12-21
- Date Revised 2016-11-16
Related Literature
Japanese
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.